# METHYLPREDNISOLONE SODIUM SUCCINATE
> **ANDA202691** · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2016-02-16
## Drug
- **FDA Application Number:** ANDA202691
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METHYLPREDNISOLONE SODIUM SUCCINATE
- **Generic name:** METHYLPREDNISOLONE SODIUM SUCCINATE
- **Active ingredients:** METHYLPREDNISOLONE SODIUM SUCCINATE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** HIKMA
- **Manufacturer:** Hikma Pharmaceuticals USA Inc.
- **First approval:** 2016-02-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202691)
---
*MORVS · CC0 1.0*